Dr Lal PathLabs Ltd.’s first-quarter profit surged, beating analysts' estimates.
The diagnostic and healthcare testing services provider’s net profit jumped 43% year-on-year to Rs 83 crore in the quarter ended June, according to its exchange filing. That compares with the Rs 73 crore consensus estimate of analysts tracked by Bloomberg.
Sequentially, profit was up by 46%.
Dr Lal PathLabs Q1 FY24 Highlights (YoY)
Revenue rose 8% to Rs 541 crore as against an estimate of Rs 548 crore.
Ebitda was up 24% to Rs 146 crore, as compared with an estimate of Rs 135 crore.
Margin expanded to 27% from 23.4% a year ago. Analysts had forecast it at 24.7%.
Shares of Dr Lal PathLabs gained 2.48% after the results were announced, compared with a 0.76% decline in the benchmark Sensex as of 2:36 p.m. on Thursday.
RECOMMENDED FOR YOU
Iran-Israel Conflict Raises Export Concerns But Freight Stable Via Strait Of Hormuz: Chaman Lal Setia Exports
Jun 19, 2025
Power Deficit Nil, India Emerging As Energy Surplus Nation, Says Manohar Lal Khattar
Jun 10, 2025
Nifty Q4 Earnings Scorecard: India Inc Sees Steady Sailing Amid Global Turbulence
Jun 02, 2025
Bajaj Auto Q4 Results: Profit, Revenue Rise 6% On Exports Revival
May 29, 2025
POPULAR